OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Debt History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹62 Cr | ₹57 Cr | ₹68 Cr | ₹52 Cr | ₹48 Cr |
What is the latest Total Debt ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹62 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹52 Cr |
| Mar2021 | ₹48 Cr |
How is Total Debt of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹62 Cr | 8.73 | |
| Mar2024 | ₹57 Cr | -15.82 | |
| Mar2023 | ₹68 Cr | 30.43 | |
| Mar2022 | ₹52 Cr | 8.86 | |
| Mar2021 | ₹48 Cr | - | |
Compare Total Debt of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹192.8 Cr | 6.6% | 3.2% | -51.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 6.6% |
3.2% |
-51.8% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses